Bedminster, NJ, United States of America

Matthew C Pellegrini


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew C. Pellegrini

Introduction

Matthew C. Pellegrini is an accomplished inventor based in Bedminster, NJ (US). He has made significant contributions to the field of gene expression modulation, holding two patents that reflect his innovative work. His research focuses on developing methods and agents that can effectively alter gene expression and protein levels.

Latest Patents

Matthew's latest patents include "Methods and agents for screening for compounds capable of modulating gene expression." This invention relates to screening assays, compounds, and methods aimed at altering gene expression and protein levels. Specifically, it includes assays designed to identify agents that can modulate gene expression in a UTR-dependent manner.

Career Highlights

Matthew C. Pellegrini is currently associated with PTC Therapeutics, Inc., where he continues to advance his research in gene modulation. His work has the potential to impact various fields, including biotechnology and pharmaceuticals.

Collaborations

Some of his notable coworkers include Liangxian Cao and Nikolai A. Naryshkin, who collaborate with him on various projects related to gene expression.

Conclusion

Matthew C. Pellegrini's innovative contributions to gene expression modulation highlight his role as a significant inventor in the field. His patents and ongoing work at PTC Therapeutics, Inc. demonstrate his commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…